Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (2598)	1/17/2001 3:06:35 PM
From: keokalani'nui	Read Replies (1) \| Respond to of 52153

I would ask the shorts to show me the clinical trials in which the FDA has asked for or accepted troponin as a surrogate for heart tissue necrosis. I'm bluffing of course, because I don't really know (anyone know how I can quickly search for this?). But the troponin debate is relatively NEW and I believe the issue is primarily with respect to whether it is predictive of MI risk. Is there a more accepted measure of heart tissue necrosis, other than harvest and staining, than CK-MB (along with platelet activity and a lot of other stuff I don't understand)? Sorry if I am repeating myself. Wilder